In patients without heart failure or left ventricular dysfunction after acute myocardial infarction, β-blockers were not associated with reduced mortality up to 1 year.
Does β-blocker use reduce mortality in survivors of acute myocardial infarction without heart failure or ventricular dysfunction?
In survivors of acute myocardial infarction without heart failure or left ventricular systolic dysfunction, routine beta-blocker use was not associated with improved 1-year survival.
Absolute Event Rate: 0% vs 0%
Among survivors of hospitalization with AMI who did not have HF or LVSD as recorded in the hospital, the use of β-blockers was not associated with a lower risk of death at any time point up to 1 year. (β-Blocker Use and Mortality in Hospital Survivors of Acute Myocardial Infarction Without Heart Failure; NCT02786654).
Dondo et al. (Wed,) reported a other. In patients without heart failure or left ventricular dysfunction after acute myocardial infarction, β-blockers were not associated with reduced mortality up to 1 year.